234 related articles for article (PubMed ID: 32411597)
1. Radiation Recall Pneumonitis Induced by Anti-PD-1 Blockade: A Case Report and Review of the Literature.
Chen Y; Huang Z; Xing L; Meng X; Yu J
Front Oncol; 2020; 10():561. PubMed ID: 32411597
[No Abstract] [Full Text] [Related]
2. Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report.
Ye X; Yang J; Stebbing J; Peng L
BMC Pulm Med; 2022 Feb; 22(1):54. PubMed ID: 35123465
[TBL] [Abstract][Full Text] [Related]
3. Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer.
Ding X; Ji W; Li J; Zhang X; Wang L
Radiat Oncol; 2011 Mar; 6():24. PubMed ID: 21375774
[TBL] [Abstract][Full Text] [Related]
4. Radiation recall pneumonitis induced by PD-1/PD-L1 blockades: mechanisms and therapeutic implications.
Teng F; Li M; Yu J
BMC Med; 2020 Sep; 18(1):275. PubMed ID: 32943072
[TBL] [Abstract][Full Text] [Related]
5. Radiation Recall Pneumonitis After Treatment With Checkpoint Blockade Immunotherapy: A Case Series and Review of Literature.
Riviere P; Sumner W; Cornell M; Sandhu A; Murphy JD; Hattangadi-Gluth J; Bruggeman A; Kim SS; Randall JM; Sharabi AB
Front Oncol; 2021; 11():662954. PubMed ID: 33996587
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint inhibitor-related pneumonitis induced by camrelizumab: a case report and review of literature.
Li L; Lou A; Yu J
Ann Palliat Med; 2021 Jul; 10(7):8460-8466. PubMed ID: 34044548
[TBL] [Abstract][Full Text] [Related]
7. Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer.
Cousin F; Desir C; Ben Mustapha S; Mievis C; Coucke P; Hustinx R
Radiother Oncol; 2021 Apr; 157():47-55. PubMed ID: 33453313
[TBL] [Abstract][Full Text] [Related]
8. Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer.
Torresan S; Zussino G; Cortiula F; Follador A; Fasola G; Girometti R; Cereser L
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835802
[TBL] [Abstract][Full Text] [Related]
9. Radiation Recall Pneumonitis Induced by Sintilimab: A Case Report and Literature Review.
Wang M; Xu S; Zhu H
Front Immunol; 2022; 13():823767. PubMed ID: 35280981
[TBL] [Abstract][Full Text] [Related]
10. Radiation recall pneumonitis from immune checkpoint inhibitors after extra pulmonary radiation.
Kao LE; Stover D
Respirol Case Rep; 2023 Oct; 11(10):e01223. PubMed ID: 37731586
[TBL] [Abstract][Full Text] [Related]
11. Radiation Recall Pneumonitis COVID-19 Infection Induced After Adjuvant Breast Cancer Radiotherapy. A Known Phenomenon in an Unknown Pandemic Disease: A Case Report.
Lazzari G; Giua R; Verdolino E; Solazzo AP; Benevento I; Montagna A; Castaldo G; Rago L; Silvano G
Cancer Manag Res; 2022; 14():2299-2304. PubMed ID: 35945923
[TBL] [Abstract][Full Text] [Related]
12. [Immune-related pneumonitis caused by programmed death-1 inhibitor Pembrolizumab: a case report and literature review].
Chen YL; Zhao J; Jia R; Wang HY; Zheng J; Bai CQ; Wang MZ; Xu JM
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Oct; 40(10):736-743. PubMed ID: 29050127
[No Abstract] [Full Text] [Related]
13. Radiation recall pneumonitis induced by erlotinib after palliative thoracic radiotherapy for lung cancer: Case report and literature review.
Awad R; Nott L
Asia Pac J Clin Oncol; 2016 Mar; 12(1):91-5. PubMed ID: 26846159
[TBL] [Abstract][Full Text] [Related]
14. Anlotinib improved the reactive cutaneous capillary endothelial proliferation induced by camrelizumab: a case report.
Wu R; Ju Y; Long T; Su Z; Zhu G; Liu S
Transl Cancer Res; 2022 Aug; 11(8):2940-2945. PubMed ID: 36093549
[TBL] [Abstract][Full Text] [Related]
15. Radiation recall pneumonitis induced by epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced nonsmall-cell lung cancer.
Chiang CL; Chen YW; Wu MH; Huang HC; Tsai CM; Chiu CH
J Chin Med Assoc; 2016 May; 79(5):248-55. PubMed ID: 27036494
[TBL] [Abstract][Full Text] [Related]
16. Radiation recall pneumonitis in the setting of immunotherapy and radiation: a focused review.
McGovern K; Ghaly M; Esposito M; Barnaby K; Seetharamu N
Future Sci OA; 2019 Jun; 5(5):FSO378. PubMed ID: 31245041
[TBL] [Abstract][Full Text] [Related]
17. Rapid Development of Clinically Symptomatic Radiation Recall Pneumonitis Immediately Following COVID-19 Vaccination.
Steber CR; Ponnatapura J; Hughes RT; Farris MK
Cureus; 2021 Apr; 13(4):e14303. PubMed ID: 33968515
[TBL] [Abstract][Full Text] [Related]
18. Pemetrexed-induced radiation recall dermatitis in a patient with lung adenocarcinoma: case report and literature review.
Ge J; Verma V; Hollander A; Langer C; Simone CB
J Thorac Dis; 2016 Dec; 8(12):E1589-E1593. PubMed ID: 28149588
[TBL] [Abstract][Full Text] [Related]
19. Addition of Low-Dose Decitabine to Anti-PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin Lymphoma.
Nie J; Wang C; Liu Y; Yang Q; Mei Q; Dong L; Li X; Liu J; Ku W; Zhang Y; Chen M; An X; Shi L; Brock MV; Bai J; Han W
J Clin Oncol; 2019 Jun; 37(17):1479-1489. PubMed ID: 31039052
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy Reverses Anti-PD-1 Resistance in One Patient With Advanced Non-small Lung Cell Cancer.
Zhao L; Ma B; Yang Y; Li T; Han L; Gao Q
Front Oncol; 2020; 10():507. PubMed ID: 32373522
[No Abstract] [Full Text] [Related]
[Next] [New Search]
